Quantitative analysis for InMode Ltd. (INMD) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Buy (55.0) (grade B). Gem alpha score: 50.0. 29 signals analyzed (24 differentiated alt-data).
INMD stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $14.15 | $13.92 | $13.96 |
| 2026-05-11 | $14.01 | $13.64 | $13.77 |
| 2026-05-21 | $14.10 | $13.80 | $13.83 |
| 2026-06-03 | $13.51 | $13.35 | $13.49 |
| 2026-06-15 | $13.58 | $13.40 | $13.57 |
| 2026-06-26 | $14.81 | $14.37 | $14.63 |
| 2026-07-09 | $15.37 | $14.83 | $15.01 |
| 2026-07-21 | $15.40 | $15.20 | $15.36 |
| 2026-07-31 | $15.19 | $15.00 | $15.14 |
| 2026-08-12 | $15.28 | $15.02 | $15.23 |
| 2026-08-24 | $15.17 | $15.03 | $15.10 |
| 2026-09-03 | $15.04 | $14.77 | $14.84 |
How InMode Ltd. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| GDRX | GoodRx Holdings, Inc. | $874M | — |
| SPTX | Seaport Therapeutics, Inc. Common Stock | $837M | — |
| LXRX | Lexicon Pharmaceuticals, Inc. | $982M | — |
| DRTS | Alpha Tau Medical Ltd. | $984M | — |
View all Health Care stocks by valuation and signals →
InMode Ltd. (INMD) scores Buy (55.0), and the composite conceals a 76-point disagreement between its dimensions. It is strongest on valuation at 78 and technicals at 67, and weakest on analyst consensus at 32 and ML forecast at 2. A stock can carry valuation that high while ML forecast sits at 2; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| valuation | 78 |
| technicals | 67 |
| AI Alpha (gem) | 57 |
| analyst consensus | 32 |
| ML forecast | 2 |
StoQuant analyzes 29 signals (24 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on InMode Ltd. (INMD): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/INMD"><img src="https://stoquant.com/badge/INMD.svg" alt="InMode Ltd. (INMD) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.